Exosome Research Market by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User - Global Forecast to 2026
Description
Exosome Research Market by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User - Global Forecast to 2026
The exosome research market is valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based
procedures.
“By product & service, the kits & reagents segment accounted for the largest share of the exosome research market”
Based on product and service, the exosomes market is segmented into kits & reagents, instruments, and services. The kits & reagents segment is further divided into antibodies, isolation, purification, quantitation kits & reagents, and other kits & reagents. Circulating exosomal microRNAs (miRNAs) have emerged as valuable biomarker candidates, making it imperative to characterize these exosomes carefully. This has propelled the use of these entities in exosome research to develop easy-to-use kits and reagents. Additionally, isolation and purification are critical steps in exosome research protocols, contributing to their large-scale adoption in the market.
“Asia Pacific: The fastest-growing region in the exosome research market.”
The Asia Pacific exosome research market is registered to grow at the fastest pace during the forecast period. The rising disposable income, infrastructural developments, and penetration of cutting-edge diagnostic technologies in Asian countries such as India and China offer significant growth opportunities for manufacturers and distributors of exosomes.
“North America: The North America region accounted for the largest share of the exosome research market”
North America accounted for the largest share of the exosome research market. The US is the key revenue contributor to the North American exosome research market. The high prevalence of cancer coupled with the increasing demand for early and effective disease diagnosis and treatment is the key factor driving market growth in the US.
Breakdown of primaries
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
By Respondent–
Supply Side- 40%, Demand Side- 60%
By Designation—
Executives- 25%, CXOs & Directors--30%, Managers - 45%
By Region—
North America - 40%, Europe - 25%, APAC – 20%, LATAM- 10%, MEA- 5%
Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Bio-Techne (US), System Biosciences, LLC. (US), NX PharmaGen (US), Miltenyi Biotec (Germany), AMS Biotechnology (Europe) Limited (UK), NanoSomiX (US), Lonza (Switzerland), and Norgen Biotek Corp. (Canada) are some of the leading players operating in the global exosome research market.
Research Coverage:
The report segments the exosome research market based on region (North America, Europe, Asia Pacific, and Rest of the World), Product & Service (Kits & Reagents (Antibodies, Isolation, Purification, Quantitation Kits & Reagents, Other Kits & Reagents), Instruments, Services), Indication (Cancer (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Other Cancers), Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Other Cancers), Application (Biomarkers, Vaccine Development, Tissue Regeneration, and Other Applications), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinical Testing Laboratories).
The report also provides a comprehensive review of market drivers, challenges, and opportunities in the exosome research market.
Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the exosome research market and provides them information on key market drivers, challenges, and opportunities.
The exosome research market is valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based
procedures.
“By product & service, the kits & reagents segment accounted for the largest share of the exosome research market”
Based on product and service, the exosomes market is segmented into kits & reagents, instruments, and services. The kits & reagents segment is further divided into antibodies, isolation, purification, quantitation kits & reagents, and other kits & reagents. Circulating exosomal microRNAs (miRNAs) have emerged as valuable biomarker candidates, making it imperative to characterize these exosomes carefully. This has propelled the use of these entities in exosome research to develop easy-to-use kits and reagents. Additionally, isolation and purification are critical steps in exosome research protocols, contributing to their large-scale adoption in the market.
“Asia Pacific: The fastest-growing region in the exosome research market.”
The Asia Pacific exosome research market is registered to grow at the fastest pace during the forecast period. The rising disposable income, infrastructural developments, and penetration of cutting-edge diagnostic technologies in Asian countries such as India and China offer significant growth opportunities for manufacturers and distributors of exosomes.
“North America: The North America region accounted for the largest share of the exosome research market”
North America accounted for the largest share of the exosome research market. The US is the key revenue contributor to the North American exosome research market. The high prevalence of cancer coupled with the increasing demand for early and effective disease diagnosis and treatment is the key factor driving market growth in the US.
Breakdown of primaries
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
By Respondent–
Supply Side- 40%, Demand Side- 60%
By Designation—
Executives- 25%, CXOs & Directors--30%, Managers - 45%
By Region—
North America - 40%, Europe - 25%, APAC – 20%, LATAM- 10%, MEA- 5%
Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Bio-Techne (US), System Biosciences, LLC. (US), NX PharmaGen (US), Miltenyi Biotec (Germany), AMS Biotechnology (Europe) Limited (UK), NanoSomiX (US), Lonza (Switzerland), and Norgen Biotek Corp. (Canada) are some of the leading players operating in the global exosome research market.
Research Coverage:
The report segments the exosome research market based on region (North America, Europe, Asia Pacific, and Rest of the World), Product & Service (Kits & Reagents (Antibodies, Isolation, Purification, Quantitation Kits & Reagents, Other Kits & Reagents), Instruments, Services), Indication (Cancer (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Other Cancers), Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Other Cancers), Application (Biomarkers, Vaccine Development, Tissue Regeneration, and Other Applications), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinical Testing Laboratories).
The report also provides a comprehensive review of market drivers, challenges, and opportunities in the exosome research market.
Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the exosome research market and provides them information on key market drivers, challenges, and opportunities.
Table of Contents
183 Pages
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- MARKET SCOPE
- CURRENCY
- LIMITATIONS
- STAKEHOLDERS
- SUMMARY OF CHANGES
- RESEARCH DATA
- MARKET SIZE ESTIMATION
- GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
- MARKET BREAKDOWN AND DATA TRIANGULATION
- INSIGHTS FROM PRIMARIES
- RESEARCH ASSUMPTIONS
- RISK ANALYSIS
- EXECUTIVE SUMMARY
- EXOSOME RESEARCH MARKET OVERVIEW
- NORTH AMERICA: EXOSOME RESEARCH MARKET SHARE, BY PRODUCT & SERVICE AND COUNTRY (2020)
- EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021 VS. 2026 (USD MILLION)
- INTRODUCTION
- MARKET DYNAMICS
- IMPACT OF COVID-19 OUTBREAK ON EXOSOME RESEARCH MARKET
- ECOSYSTEM AND VALUE CHAIN ANALYSIS
- REGULATORY ANALYSIS
- INTRODUCTION
- KITS & REAGENTS
- SERVICES
- INSTRUMENTS
- INTRODUCTION
- CANCER
- NEURODEGENERATIVE DISEASES
- CARDIOVASCULAR DISEASES
- INFECTIOUS DISEASES
- OTHER INDICATIONS
- INTRODUCTION
- BIOMARKERS
- VACCINE DEVELOPMENT
- TISSUE REGENERATION
- OTHER APPLICATIONS
- INTRODUCTION
- STEM CELL-DERIVED EXOSOME MANUFACTURING SERVICES
- DENDRITIC CELL-DERIVED EXOSOME MANUFACTURING SERVICES
- OTHER MANUFACTURING SERVICES
- INTRODUCTION
- ACADEMIC & RESEARCH INSTITUTES
- PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- HOSPITAL & CLINICAL TESTING LABORATORIES
- INTRODUCTION
- NORTH AMERICA
- EUROPE
- ASIA PACIFIC
- REST OF THE WORLD
- INTRODUCTION
- RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
- MARKET SHARE ANALYSIS
- COMPANY EVALUATION QUADRANT
- COMPETITIVE BENCHMARKING
- COMPETITIVE SCENARIO AND TRENDS
- KEY COMPANIES
- OTHER PLAYERS
- DISCUSSION GUIDE
- KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- AVAILABLE CUSTOMIZATIONS
- RELATED REPORT
- AUTHOR DETAILS
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.